Pro Medicus Limited has secured a five-year contract renewal worth A$16 million with The Ohio State University Wexner Medical Center, marking another significant milestone for the healthcare imaging software company. The renewal extends the company’s relationship with one of North America’s largest academic medical centers and demonstrates sustained customer demand for its Visage platform.
What makes this renewal particularly noteworthy is not just the contract duration or value, but the scope of the expanded relationship. The agreement includes two new modules, Visage 7 Workflow and Visage 7 Cardiology Imaging, in addition to the existing services. This expansion suggests the medical center’s confidence in Pro Medicus’s broader capabilities and its willingness to consolidate more imaging workflows onto the Visage platform. The contract is structured on a transaction-based model, meaning Pro Medicus has upside potential beyond the stated A$16 million minimum if imaging volumes increase.
The Ohio State University Wexner Medical Center is a substantial enterprise, operating six hospitals with approximately 22,000 staff and 2,000 physicians supporting over 1,400 inpatient beds. As the teaching hospital for Ohio State University’s College of Medicine, it carries considerable prestige and represents the type of large, complex healthcare environment where Pro Medicus’s imaging platform must perform reliably. Securing renewal with such an institution serves as a strong validator of the company’s technology and service quality.
The negotiation itself speaks to Pro Medicus’s competitive positioning. The company confirmed that renewal terms included increased minimum payments and higher per-transaction fees compared to the previous agreement. This suggests the company successfully negotiated improved pricing despite an increasingly competitive market for healthcare IT solutions. The fact that a major customer accepted these higher costs implies genuine value perception rather than a captive relationship.
Contextually, Pro Medicus CEO Dr Sam Hupert noted that this renewal brings the company’s total contract renewals for the financial year to A$141 million. This milestone underscores a strong retention record. In healthcare software, customer retention is a crucial metric because it indicates solution stickiness and customer satisfaction. Companies that lose significant market share face declining renewal rates, so maintaining a high renewal book across an installed base suggests Pro Medicus continues to deliver value that customers cannot easily replace.
For investors, the broader narrative here concerns whether Pro Medicus can maintain pricing discipline while growing its customer base. The Ohio State renewal demonstrates both retention and pricing power, though the true test lies in scaling this performance across hundreds of customers globally. The modular expansion through Workflow and Cardiology modules shows the company is successfully cross-selling additional functionality rather than relying solely on contract extensions. This announcement is price sensitive and flagged as material by the ASX.
View the full ASX announcement (PDF)
About Pro Medicus Limited (ASX: PME)
Pro Medicus Limited is an Australian health imaging software company headquartered in Victoria that develops advanced diagnostic imaging solutions for the global healthcare market. The company’s main business segment centers on its Visage imaging platform, a viewer and analysis solution used by hospitals and medical institutions to manage and interpret medical images. Pro Medicus operates primarily through its U.S. subsidiary Visage Imaging, Inc., serving major healthcare systems across North America and internationally on a transaction-based licensing model.
If you would like to discuss this announcement or how it might affect your portfolio, request a callback or call us on 1300 889 603.
